William Julio de Jesus, MD
Geriatric Psychiatry · Bayamon, PRNPI 1871578997
Payments from drug & device makers
Across 271 payments — averaging $7606.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly Export S.A. Puerto Rico Branch$1.3M
- Genentech, Inc.$446K
- Sage Therapeutics, LLC$95K
- Johnson & Johnson$83K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$38K
- Eli Lilly$36K
- plus $56K from 13 others
Across 8 payments — averaging $8428.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly Export S.A. Puerto Rico Branch$53K
- Eli Lilly$14K
What the payments were for
- Consulting fees$3,2254%
- Speaking & faculty fees$72,99383%
- Travel & lodging$6,0387%
- Food & beverage$5,2036%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly Export S.A. Puerto Rico Branch | 13 | $1,307,629 |
| Genentech, Inc. | 42 | $445,998 |
| Sage Therapeutics, LLC | 1 | $94,743 |
| Johnson & Johnson | 114 | $83,058 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $38,267 |
| Eli Lilly | 17 | $36,114 |
| E.r. Squibb & Sons, L.L.C. | 15 | $28,094 |
| Avanir Pharmaceuticals, Inc. | 8 | $21,404 |
| AbbVie | 37 | $3,214 |
| Merck | 2 | $2,212 |
| Otsuka America Pharmaceutical, Inc. | 3 | $142 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $119 |
| Eisai Inc. | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
| Sunovion Pharmaceuticals Inc. | 4 | $73 |
| Pfizer Pharmaceuticals LLC | 1 | $27 |
| Harmony Biosciences LLC | 1 | $25 |
| Shire North American Group Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$53,093
- INVEGA TRINZA$37,186
- INVEGA$26,177
- VRAYLAR$2,401
- AUSTEDO$125
- XARELTO$125
- COBENFY$119
- ZEPBOUND$119
- Leqembi$100
How this compares
Too few geriatric psychiatry providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 32 | $91,790 |
| Clonazepam | 1,797 | $19,828 |
| BelsomraSuvorexant | 43 | $19,456 |
| Rivastigmine | 119 | $14,917 |
| Sertraline Hcl | 1,573 | $12,767 |
| Trazodone Hcl | 1,412 | $10,777 |
| TrintellixVortioxetine Hydrobromide | 22 | $10,770 |
| PristiqDesvenlafaxine Succinate | 23 | $10,201 |
| Seroquel XrQuetiapine Fumarate | 13 | $9,912 |
| Memantine Hcl ErMemantine Hcl | 146 | $9,488 |
| Bupropion XlBupropion Hcl | 410 | $9,268 |
| Buspirone Hcl | 637 | $8,019 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 131 | $7,236 |
| Paliperidone ErPaliperidone | 30 | $7,043 |
| Duloxetine Hcl | 512 | $6,896 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $83,058 | $91,79032 claims |
| MerckBelsomra | $2,212 | $19,45643 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $95 | $10,77022 claims |
| Lilly USA, LLCOlanzapine | $119 | $2,040140 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few geriatric psychiatry providers in Puerto Ricoon file to place this against a meaningful peer group, so we don't.
Other geriatric psychiatry in Bayamon
- Ruben Bravo ValverdeBayamon$898
- Sylma BatistaBayamon$146
- Vilma McCarthySan Juan$3K
- Magaly JohnsonManati$290
- Marinelly Martinez GarriSan Juan$89
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.